SG11201808487UA - Carboxylic acids for early childhood application - Google Patents
Carboxylic acids for early childhood applicationInfo
- Publication number
- SG11201808487UA SG11201808487UA SG11201808487UA SG11201808487UA SG11201808487UA SG 11201808487U A SG11201808487U A SG 11201808487UA SG 11201808487U A SG11201808487U A SG 11201808487UA SG 11201808487U A SG11201808487U A SG 11201808487UA SG 11201808487U A SG11201808487U A SG 11201808487UA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- pct
- application
- english
- patient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property 11111111111111111111111111111111111111111111111111111111111111111111111111111110111111 Organization 0 International Bureau (10) International Publication Number (43) International Publication Date ......0\"\" WO 2017/198705 Al 23 November 2017 (23.11.2017) WIPO I PCT (51) International Patent Classification: A61K 31/19 (2006.01) A61P 17/16 (2006.01) A61K 9/00 (2006.01) A61P 17/00 (2006.01) (21) International Application Number: PCT/EP2017/061835 (22) International Filing Date: 17 May 2017 (17.05.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 16169888.1 17 May 2016 (17.05.2016) EP (71) Applicant: PROPONENT BIOTECH GMBH [CH/CH]; c/o Premium Business Center Westside AG, Baarerstrasse 135, 6301 Zug (CH). (72) Inventor: ERNST, Bettina; Klusdorfli 2, 8032 Ziirich (CH). (74) Agent: VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB; SiebertstraBe 3, 81675 — = Miinchen (DE). Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, (81) = _ = — = TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. = _ Designated States (unless otherwise indicated, for every (84) = kind of regional protection available): ARIPO (BW, GH, = _ _ GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, = UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, = TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, = EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, = MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, — TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). = — Published: ,- 1 — kr) with international search report (Art. 21(3)) 0 IN GC (54) Title: CARBOXYLIC ACIDS FOR EARLY CHILDHOOD APPLICATION 1-1 ---- (57) : The present invention relates to a pharmaceutical composition comprising as active ingredient a carboxylic acid or a IN pharmaceutically acceptable salt thereof for use in improving barrier function of the skin, wherein the pharmaceutical composition is C::::) administered to an infant. The invention also relates to a method for treating and/or preventing a skin disease of a patient, the method N comprising administering an effective amount of a carboxylic acid or a pharmaceutically acceptable salt thereof to a patient in need n thereof.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16169888 | 2016-05-17 | ||
| PCT/EP2017/061835 WO2017198705A1 (en) | 2016-05-17 | 2017-05-17 | Carboxylic acids for early childhood application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201808487UA true SG11201808487UA (en) | 2018-10-30 |
Family
ID=56014858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201808487UA SG11201808487UA (en) | 2016-05-17 | 2017-05-17 | Carboxylic acids for early childhood application |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20190160030A1 (en) |
| EP (1) | EP3458044A1 (en) |
| JP (1) | JP2019516798A (en) |
| KR (1) | KR20190008236A (en) |
| CN (1) | CN109152755A (en) |
| AU (1) | AU2017266729A1 (en) |
| BR (1) | BR112018072183A2 (en) |
| CA (1) | CA3020558A1 (en) |
| CL (1) | CL2018003269A1 (en) |
| MX (1) | MX2018013474A (en) |
| RU (1) | RU2018143557A (en) |
| SG (1) | SG11201808487UA (en) |
| WO (1) | WO2017198705A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110403914A (en) * | 2019-06-13 | 2019-11-05 | 兰溪市立顺生物有限公司 | Carboxylic acid for children's early stage application |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0617191D0 (en) * | 2006-08-31 | 2006-10-11 | York Pharma Plc | Improvements in pharmaceutical compositions |
| AU2007214300B2 (en) * | 2007-08-29 | 2009-11-05 | Sunny Pharmtech, Inc. | Method for Ameliorating Pruritus |
| US20130004590A1 (en) * | 2011-06-28 | 2013-01-03 | Lin Connie B | Zinc oxide/acid containing compositions and methods for treating and/or preventing enzymatic irritation |
-
2017
- 2017-05-17 EP EP17723140.4A patent/EP3458044A1/en not_active Withdrawn
- 2017-05-17 CN CN201780030745.4A patent/CN109152755A/en active Pending
- 2017-05-17 RU RU2018143557A patent/RU2018143557A/en not_active Application Discontinuation
- 2017-05-17 JP JP2019513482A patent/JP2019516798A/en active Pending
- 2017-05-17 KR KR1020187033156A patent/KR20190008236A/en unknown
- 2017-05-17 MX MX2018013474A patent/MX2018013474A/en unknown
- 2017-05-17 CA CA3020558A patent/CA3020558A1/en not_active Abandoned
- 2017-05-17 SG SG11201808487UA patent/SG11201808487UA/en unknown
- 2017-05-17 BR BR112018072183-2A patent/BR112018072183A2/en not_active Application Discontinuation
- 2017-05-17 WO PCT/EP2017/061835 patent/WO2017198705A1/en active Application Filing
- 2017-05-17 US US16/097,746 patent/US20190160030A1/en not_active Abandoned
- 2017-05-17 AU AU2017266729A patent/AU2017266729A1/en not_active Abandoned
-
2018
- 2018-11-16 CL CL2018003269A patent/CL2018003269A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20190008236A (en) | 2019-01-23 |
| WO2017198705A1 (en) | 2017-11-23 |
| MX2018013474A (en) | 2019-08-12 |
| US20190160030A1 (en) | 2019-05-30 |
| CN109152755A (en) | 2019-01-04 |
| CA3020558A1 (en) | 2017-11-23 |
| JP2019516798A (en) | 2019-06-20 |
| CL2018003269A1 (en) | 2019-02-22 |
| EP3458044A1 (en) | 2019-03-27 |
| AU2017266729A1 (en) | 2018-10-18 |
| RU2018143557A (en) | 2020-06-17 |
| BR112018072183A2 (en) | 2019-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201908330PA (en) | Farnesoid x receptor agonists and uses thereof | |
| SG11201407961WA (en) | Risperidone or paliperidone implant formulation | |
| SG11201811470PA (en) | Pyrazolopyrimidine derivatives as kinase inhibitor | |
| SG11201909155VA (en) | Ask1 inhibitor compounds and uses thereof | |
| SG11201901534VA (en) | Combination therapy with controlled-release cnp agonists | |
| SG11201407971QA (en) | Paliperidone implant formulation | |
| SG11201907604UA (en) | Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan | |
| SG11201900349VA (en) | Somatostatin modulators and uses thereof | |
| SG11201808237UA (en) | Substituted indole compound derivatives as dengue viral replication inhibitors | |
| SG11201811442UA (en) | Formulation of a peptide vaccine | |
| SG11201810628XA (en) | Nasal pharmaceutical compositions with a porous excipient | |
| SG11201906436VA (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
| SG11201808270PA (en) | Substituted indoline derivatives as dengue viral replication inhibitors | |
| SG11201808138YA (en) | Substituted indole derivatives as dengue viral replication inhibitors | |
| SG11201807597UA (en) | Methods of treating depression using orexin-2 receptor antagonists | |
| SG11201907804QA (en) | Pharmaceutical composition comprising selexipag | |
| SG11201900558RA (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| SG11201407397WA (en) | Formulations and methods for vaginal delivery of antiprogestins | |
| SG11201901986SA (en) | Process for the manufacture of a solid pharmaceutical adminstration form | |
| SG11201811580SA (en) | Compositions, devices, and methods for the treatment of alcohol use disorder | |
| SG11201804587QA (en) | Isoindole compounds | |
| SG11201805755SA (en) | Methods of administering hepcidin | |
| SG11201908691PA (en) | Compounds and methods for the treatment of parasitic diseases | |
| SG11201901048VA (en) | Pharmaceutical compositions and uses directed to lysosomal storage disorders | |
| SG11201900214UA (en) | Iso-citrate dehydrogenase (idh) inhibitor |